Replimune Group, Inc. - Common stock, par value $0.001 per share (REPL)

CUSIP: 76029N106

Q4 2022 13F Holders as of 31 Dec 2022

Holder snapshot 7 signals
Share change
+6,787,254
Put/Call ratio
0.78%
SEC-reported price per share
$27.20
Number of holders
135
Value change
+$189,427,869
Number of buys
95
Open additional details 1 more signal available
Number of sells
26
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
84,030,529

Security key

76029N106

Report period

Q4 2022

Institutions

135

Top holders

10

Ownership snapshot

Top reported holders of REPL - Replimune Group, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Omega Fund IV, L.P.
Disclosed value leader
Omega Fund IV, L.P.
Comparable rows
0/15
Latest evidence
30 Sep 2022
3/4/5 13F Highest disclosed value: $103,049,420 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Omega Fund IV, L.P. has the largest disclosed position value at $103.05M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Omega Fund IV, L.P.'s linked filing trail.
Disclosed position value Top 5
Omega Fund IV, L.P. $103.05M
Omega Fund Management, LLC $74.06M
PRICE T ROWE ASSOCIATES INC /MD/ $72.04M
BAKER BROS. ADVISORS LP $67.25M
Redmile Group, LLC $62.95M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Omega Fund IV, L.P.
3/4/5
10%+ Owner
—
mixed-class rows
$103,049,420
9,453,260 shares
mixed-class rows
— 14 Mar 2022
Omega Fund Management, LLC
13F
Company
13F
—
denominator unverified
$74,056,000
4,288,154 shares
— 30 Sep 2022
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$72,037,000
4,171,171 shares
— 30 Sep 2022
BAKER BROS. ADVISORS LP
13F
Company
13F
—
denominator unverified
$67,247,000
3,893,843 shares
— 30 Sep 2022
Redmile Group, LLC
13F
Company
13F
—
denominator unverified
$62,954,000
3,645,309 shares
— 30 Sep 2022
Atlas Venture Life Science Advisors, LLC
13F
Company
13F
—
denominator unverified
$53,680,000
3,108,300 shares
— 30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
135
Shares
48,204,772
Rows available
135
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
103
Q4 2022 holders
135
Holder diff
32
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .